MX391220B - Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. - Google Patents
Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.Info
- Publication number
- MX391220B MX391220B MX2019005748A MX2019005748A MX391220B MX 391220 B MX391220 B MX 391220B MX 2019005748 A MX2019005748 A MX 2019005748A MX 2019005748 A MX2019005748 A MX 2019005748A MX 391220 B MX391220 B MX 391220B
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- biomarkers
- renal function
- kidney
- biomarkers related
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title abstract 4
- 230000003907 kidney function Effects 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 208000020832 chronic kidney disease Diseases 0.000 abstract 2
- 208000009304 Acute Kidney Injury Diseases 0.000 abstract 1
- 208000033626 Renal failure acute Diseases 0.000 abstract 1
- 201000011040 acute kidney failure Diseases 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 150000003384 small molecules Chemical class 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361822965P | 2013-05-14 | 2013-05-14 | |
| PCT/US2014/037762 WO2014186311A1 (en) | 2013-05-14 | 2014-05-13 | Biomarkers related to kidney function and methods using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019005748A MX2019005748A (es) | 2019-08-12 |
| MX391220B true MX391220B (es) | 2025-03-21 |
Family
ID=51898805
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019005748A MX391220B (es) | 2013-05-14 | 2014-05-13 | Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. |
| MX2015015561A MX365061B (es) | 2013-05-14 | 2014-05-13 | Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015015561A MX365061B (es) | 2013-05-14 | 2014-05-13 | Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10539575B2 (enExample) |
| EP (3) | EP2997366B1 (enExample) |
| JP (1) | JP6595984B2 (enExample) |
| CN (2) | CN105209909B (enExample) |
| AU (1) | AU2014265669B2 (enExample) |
| BR (1) | BR112015028253A2 (enExample) |
| CA (2) | CA3184836A1 (enExample) |
| ES (2) | ES2702123T3 (enExample) |
| MX (2) | MX391220B (enExample) |
| WO (1) | WO2014186311A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3184836A1 (en) * | 2013-05-14 | 2014-11-20 | Metabolon, Inc. | Biomarkers related to kidney function and methods using the same |
| CN111239415B (zh) | 2013-10-17 | 2024-03-26 | 综合医院公司 | 鉴定响应于用于自身免疫性疾病的治疗的受试者的方法以及用于治疗该疾病的组合物 |
| US10254272B2 (en) * | 2015-01-09 | 2019-04-09 | Global Genomics Group, LLC | Blood based biomarkers for diagnosing atherosclerotic coronary artery disease |
| WO2016115496A1 (en) * | 2015-01-15 | 2016-07-21 | Joslin Diabetes Center | Metabolite biomarkers predictive of renal disease in diabetic patients |
| EP3355914B1 (en) | 2015-09-29 | 2024-03-06 | The General Hospital Corporation | A composition comprising bcg for reducing cholesterol. |
| US20170234874A1 (en) * | 2015-10-07 | 2017-08-17 | Clearbridge Biophotonics Pte Ltd. | Integrated visual morphology and cell protein expression using resonance-light scattering |
| US12057228B1 (en) | 2015-12-30 | 2024-08-06 | Cerner Innovation, Inc. | Predicting newly incident chronic kidney disease |
| AU2017301949B2 (en) * | 2016-07-28 | 2021-09-23 | Metabolon, Inc. | Compounds, reagents, and uses thereof |
| EP3552022B1 (en) * | 2016-11-25 | 2021-06-09 | Implexion AB | Metabolic disorders |
| WO2018118630A1 (en) | 2016-12-19 | 2018-06-28 | Metabolon, Inc. | Mass spectrometry assay method for detection and quantitation of kidney function metabolites |
| CN108956790A (zh) * | 2017-05-18 | 2018-12-07 | 中国人民解放军第二军医大学第二附属医院 | 一组氨基酸标志物在急性肾损伤诊断试剂盒中的应用 |
| CN107132266A (zh) * | 2017-06-21 | 2017-09-05 | 佛山科学技术学院 | 一种基于随机森林的水质分类方法及系统 |
| EP3665705B1 (en) | 2017-08-08 | 2024-12-18 | Fresenius Medical Care Holdings, Inc. | Systems and methods for treating and estimating progression of chronic kidney disease |
| CN107326093B (zh) * | 2017-09-04 | 2020-01-21 | 东南大学 | 基于Taqman探针的慢性肾脏病相关基因检测荧光定量PCR一步法试剂盒及其应用 |
| CA3077029A1 (en) * | 2017-09-28 | 2019-04-04 | Metabolon, Inc. | Compounds, reagents, and uses thereof |
| CA3089817A1 (en) * | 2018-01-19 | 2019-07-25 | Mars, Incorporated | Biomarkers and classification algorithms for chronic kidney disease in cats |
| US20210327589A1 (en) * | 2018-07-14 | 2021-10-21 | Mars, Incorporated | Biomarkers and test models for chronic kidney disease |
| WO2020171158A1 (ja) * | 2019-02-20 | 2020-08-27 | 株式会社パートナーファーム | 固相反応チップ及びこれを用いた測定方法 |
| WO2021018774A1 (en) * | 2019-07-26 | 2021-02-04 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Ergothioneine, s-methyl-ergothioneine, and uses thereof |
| CN112305089B (zh) * | 2019-07-26 | 2022-04-29 | 长沙都正生物科技股份有限公司 | 一种慢性肾病诊断生物标记物及其应用 |
| CN111487338B (zh) * | 2020-04-16 | 2022-06-10 | 中南大学湘雅二医院 | 一种与肾功能相关的无创生物标记物及其应用 |
| WO2021232211A1 (zh) * | 2020-05-19 | 2021-11-25 | 深圳市中医院 | 诊断肾病的标志物以及诊断方法 |
| KR102697110B1 (ko) | 2020-12-07 | 2024-08-22 | 킴벌리-클라크 월드와이드, 인크. | 대사산물을 검출하기 위한 방법 및 소비자 제품 |
| CN114910587B (zh) * | 2022-05-12 | 2024-03-19 | 军科正源(上海)生物医药科技有限公司 | 一种尿液检测用高效液相-串联质谱分析方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02196787A (ja) | 1989-01-25 | 1990-08-03 | Otsuka Pharmaceut Co Ltd | シュードウリジン誘導体 |
| JPH0661278B2 (ja) | 1990-09-18 | 1994-08-17 | 旭化成工業株式会社 | ミオイノシトールの高感度定量法および定量用組成物 |
| US5712084A (en) * | 1995-09-08 | 1998-01-27 | Research Corporation Technologies, Inc. | Donor kidney viability test for improved preservation |
| CN101377492B (zh) | 2007-08-29 | 2014-04-23 | 北京九强生物技术股份有限公司 | 胱抑素c测定试剂盒 |
| EP2324354B1 (en) * | 2008-08-29 | 2014-07-16 | Astute Medical, Inc. | Methods for prognosis of acute renal failure |
| US9421330B2 (en) * | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
| CN104034901A (zh) * | 2008-11-22 | 2014-09-10 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| WO2010124269A1 (en) | 2009-04-24 | 2010-10-28 | National Center For Genome Resources | Methods for diagnosis of sepsis and risk of death |
| JP5197846B2 (ja) * | 2009-04-30 | 2013-05-15 | 紀陽 田仲 | 腎疾患重篤度を判定する方法又は装置若しくはその作動方法 |
| US8637482B2 (en) * | 2009-06-08 | 2014-01-28 | Quark Pharmaceuticals, Inc. | Methods for treating chronic kidney disease |
| JP5757626B2 (ja) | 2009-09-04 | 2015-07-29 | 国立大学法人東北大学 | ヒトにおける新たな腎疾患マーカー物質 |
| KR20120123056A (ko) | 2009-12-20 | 2012-11-07 | 아스튜트 메디컬 인코포레이티드 | 신손상 및 신부전을 진단 및 예측하는 방법 및 조성물 |
| WO2011146683A1 (en) * | 2010-05-19 | 2011-11-24 | Metabolon, Inc. | Methods and reagents for metabolomics and histology in a biological sample and a kit for the same |
| CA2802273A1 (en) | 2010-08-06 | 2012-02-09 | Pronota N.V. | Perlecan as a biomarker for renal dysfunction |
| JP5916058B2 (ja) | 2011-08-26 | 2016-05-11 | 国立大学法人東北大学 | 細胞ストレス状態のバイオマーカー |
| KR20140074293A (ko) | 2011-09-14 | 2014-06-17 | 바스프 에스이 | 신장 독성을 평가하기 위한 수단 및 방법 |
| WO2013048344A1 (en) * | 2011-09-29 | 2013-04-04 | National University Of Singapore | Urinary metabolomic markers for renal insufficiency |
| CA3184836A1 (en) * | 2013-05-14 | 2014-11-20 | Metabolon, Inc. | Biomarkers related to kidney function and methods using the same |
| AU2017301949B2 (en) * | 2016-07-28 | 2021-09-23 | Metabolon, Inc. | Compounds, reagents, and uses thereof |
-
2014
- 2014-05-13 CA CA3184836A patent/CA3184836A1/en active Pending
- 2014-05-13 JP JP2016514016A patent/JP6595984B2/ja active Active
- 2014-05-13 EP EP14797070.1A patent/EP2997366B1/en active Active
- 2014-05-13 CA CA2911204A patent/CA2911204C/en active Active
- 2014-05-13 ES ES14797070T patent/ES2702123T3/es active Active
- 2014-05-13 CN CN201480027332.7A patent/CN105209909B/zh active Active
- 2014-05-13 AU AU2014265669A patent/AU2014265669B2/en active Active
- 2014-05-13 MX MX2019005748A patent/MX391220B/es unknown
- 2014-05-13 CN CN201910484069.9A patent/CN110196335A/zh active Pending
- 2014-05-13 WO PCT/US2014/037762 patent/WO2014186311A1/en not_active Ceased
- 2014-05-13 EP EP19176215.2A patent/EP3546940B1/en active Active
- 2014-05-13 EP EP18183240.3A patent/EP3410115A1/en not_active Withdrawn
- 2014-05-13 ES ES19176215T patent/ES2871823T3/es active Active
- 2014-05-13 MX MX2015015561A patent/MX365061B/es active IP Right Grant
- 2014-05-13 BR BR112015028253A patent/BR112015028253A2/pt not_active Application Discontinuation
- 2014-05-13 US US14/889,930 patent/US10539575B2/en active Active
-
2019
- 2019-12-02 US US16/700,098 patent/US20200103417A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1218331A1 (zh) | 2017-02-10 |
| AU2014265669B2 (en) | 2020-05-14 |
| EP3546940A1 (en) | 2019-10-02 |
| HK1222905A1 (en) | 2017-07-14 |
| EP3546940B1 (en) | 2021-02-17 |
| MX365061B (es) | 2019-05-22 |
| WO2014186311A1 (en) | 2014-11-20 |
| CN110196335A (zh) | 2019-09-03 |
| US20200103417A1 (en) | 2020-04-02 |
| CN105209909B (zh) | 2019-06-07 |
| US20160116486A1 (en) | 2016-04-28 |
| MX2015015561A (es) | 2016-02-05 |
| EP2997366A4 (en) | 2017-04-12 |
| BR112015028253A2 (pt) | 2017-07-25 |
| CN105209909A (zh) | 2015-12-30 |
| AU2014265669A1 (en) | 2015-12-24 |
| CA2911204C (en) | 2023-03-28 |
| US10539575B2 (en) | 2020-01-21 |
| JP6595984B2 (ja) | 2019-10-23 |
| JP2016520192A (ja) | 2016-07-11 |
| ES2702123T3 (es) | 2019-02-27 |
| EP2997366A1 (en) | 2016-03-23 |
| EP3410115A1 (en) | 2018-12-05 |
| CA3184836A1 (en) | 2014-11-20 |
| CA2911204A1 (en) | 2014-11-20 |
| MX2019005748A (es) | 2019-08-12 |
| ES2871823T3 (es) | 2021-11-02 |
| EP2997366B1 (en) | 2018-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX391220B (es) | Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. | |
| IL289514B1 (en) | Assays for determining plasma kallikrein system biomarkers | |
| DK3041576T3 (da) | Fremgangsmåder til at detektere nyresygdom | |
| EP2968749A4 (en) | DOUBLE-ACTING INFUSION SYSTEM | |
| EP2855188A4 (en) | LOCKING DIFFERENTIAL ARRANGEMENT | |
| CL2014002242A1 (es) | Acoplamiento de dispositivo movil para reproducir un test de droga, que comprende una carcasa, una pluralidad de adaptadores del test de droga, uno o mas alojamientos del dispositivo, para acoplarse de forma desmontable a la carcasa; montaje fijo; metodo para analizar resultados | |
| EP2668379A4 (en) | OIL PUMP WITH SELECTABLE OUTLET PRESSURE | |
| LT2970345T (lt) | 18f-žymėti pozitronų emisijos tomografijos (pet) vizualizacijos agentai, nukreipti į prostatos atžvilgiu specifinius membranos antigenus (psma) | |
| DK2874507T3 (da) | Vandig transparent olie-i-vand-emulsion, der omfatter et emulgeret carotenoid | |
| FR3007070B1 (fr) | Ensemble pour turbomachine | |
| HUE049425T2 (hu) | GPR120 agonista biaril-származékok | |
| BR112018067292A2 (pt) | métodos e composições para a detecção e o diagnóstico de doença renal e doença periodontal | |
| BR112014026638A2 (pt) | dispositivo para quantificação do desempenho. | |
| UY35776A (es) | ?antagonistas de receptor ep3 de prostaglandina?. | |
| MX381200B (es) | Composiciones y metodos para valorar la funcion intestinal. | |
| FR3011031B1 (fr) | Ensemble rotatif pour turbomachine | |
| EP3006739A4 (en) | LIQUID PUMP | |
| PT2972368T (pt) | Biomarcadores linfocitários para determinação de resposta clínica a terapia celular | |
| LT3520811T (lt) | Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą | |
| BR302013002861S1 (pt) | Configuração aplicada em tela para computador portátil. | |
| EP2948742C0 (en) | ROTATING ORIFICE PLATE FOR DIRECT FLOW MEASUREMENT | |
| AR094118A1 (es) | Lesion renal aguda | |
| PT2972357T (pt) | Métodos para detectar moléculas numa amostra | |
| MA39623A (fr) | Systeme et methode de test de performances d'une infrastructure informatique | |
| RU2012147872A (ru) | Способ диагностики функционального почечного резерва |